NGM · Financial Statements
Jyong Biotech Ltd. (MENS) Financial Statements
$2.05
NGM: MENS
Market Cap $155.86M
Overview Financials Dividend Jyong Biotech Ltd. most recently reported annual revenue of $0, net profit of $-5.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-2.0M $-3.0M $-3.0M $-2.0M $-3.0M Net Profit $-4.0M $-7.0M $-4.0M $-3.0M $-5.0M EPS $-0.06 $-0.09 $-0.06 $-0.04 $-0.06 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $9.0M $9.0M $8.0M $6.0M $21.0M Total Liabilities $33.0M $38.0M $42.0M $43.0M $46.0M Cash $1.0M $1.0M $0 $0 $1.0M Borrowings $12.0M $14.0M $17.0M $18.0M $19.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-2.0M $-3.0M $-3.0M $-4.0M $-3.0M Investing Cash Flow $-1.0M $1.0M $0 $0 $-14.0M Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $-5.0M $2.0M $-1.0M $-2.0M $1.0M Free Cash Flow $-2.0M $-3.0M $-3.0M $-4.0M $-3.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.49 EV / EBITDA -66.23 FCF Yield 0.00% Quick Ratio 0.45 Interest Coverage -1.03 Return 1Y -75.70% Return 3Y — Return 5Y —
Screens featuring this stock